Michael B. Wallace, Fred C. Andersen Endowed Professor of Medicine at Mayo Clinic Florida, shared on LinkedIn:
“Screening for early pancreatic cancer is now recommended for individuals at increased risk, such as those with a family history, known pancreatic cysts, and genetic risk factors.
For others, we rely on subtle clues in their health, including new-onset diabetes and weight loss.
In this study, we identified a new clue: subtle changes in body composition, including loss of visceral fat, which can occur up to three years before a clinical cancer diagnosis.
Although screening CT scans are not routinely performed, many patients undergo these scans for other reasons. These ‘ambient’ clues on already available images may offer an opportunity for earlier detection and a greater chance for cure.
Thanks to Yan Bi, Aleksander Bogdanski, Koen Wijsman, Derk Klatte, Jeanin E. van Hooft, Che Ngufor, Alexander Weston, M.E. van Leerdam, Shiba K., Shrinath Patel, and our Mayo Clinic Pancreatic Cancer Early Detection team for their dedication to finding this disease early, when we have a chance to cure.
Other articles about Pancreatic Cancer on OncoDaily.